Skip to content

Opening book details…

About this Medicine article

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer : A Prostate Cancer Clinical Trials Consortium trial by Robert W. Ross; Matthew D. Galsky; Phil Febbo; Marc Barry; Jerome P. Richie; Wanling Xie; Fiona M. Fennessy; Rupal S. Bhatt; Julia Hayes; Toni K. Choueiri; Clare M. Tempany; Philip W. Kantoff; Mary E. Taplin; William K. Oh is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Robert W. Ross; Matthew D. Galsky; Phil Febbo; Marc Barry; Jerome P. Richie; Wanling Xie; Fiona M. Fennessy; Rupal S. Bhatt; Julia Hayes; Toni K. Choueiri; Clare M. Tempany; Philip W. Kantoff; Mary E. Taplin; William K. Oh
Publisher
John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley (ISSN 0008-543X)
Published
2012
Language
EN
Field
Medicine (Health Sciences)

More by Robert W. Ross; Matthew D. Galsky; Phil Febbo; Marc Barry; Jerome P. Richie; Wanling Xie; Fiona M. Fennessy; Rupal S. Bhatt; Julia Hayes; Toni K. Choueiri; Clare M. Tempany; Philip W. Kantoff; Mary E. Taplin; William K. Oh

Browse all works by Robert W. Ross; Matthew D. Galsky; Phil Febbo; Marc Barry; Jerome P. Richie; Wanling Xie; Fiona M. Fennessy; Rupal S. Bhatt; Julia Hayes; Toni K. Choueiri; Clare M. Tempany; Philip W. Kantoff; Mary E. Taplin; William K. Oh